Insider · SEC Forms 3, 4, 5
CIK 1494730
All transactions
Every Form 4 row this person reported, newest first
Insider · SEC Forms 3, 4, 5
Every Form 4 row this person reported, newest first
Meckler Jeffrey A (CIK 1506916) reported 12 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-09-11). Recent activity: Buy TVTX (10,000 shares), Buy TVTX (10,000 shares), Sell TVTX (1,700 shares), Sell TVTX (1,200 shares), Sell TVTX (14,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-11 | Travere Therapeutics, Inc. (TVTX) | Director | Buy | 10,000 | $174,400 |
| 2026-09-11 | Travere Therapeutics, Inc. (TVTX) | Director | Buy | 10,000 | $265,200 |
| 2026-09-11 | Travere Therapeutics, Inc. (TVTX) | Director | Sell | 1,700 | $111,166 |
| 2026-09-11 | Travere Therapeutics, Inc. (TVTX) | Director | Sell | 1,200 | $79,380 |
| 2026-09-11 | Travere Therapeutics, Inc. (TVTX) | Director | Sell | 14,000 | $944,488 |
| 2026-09-11 | Travere Therapeutics, Inc. (TVTX) | Director | Sell | 3,100 | $211,073 |
| 2026-05-21 | Travere Therapeutics, Inc. (TVTX) | Director | Buy | 4,000 | $0 |
| 2026-05-06 | Travere Therapeutics, Inc. (TVTX) | Director | Buy | 8,000 | $130,640 |
| 2026-05-06 | Travere Therapeutics, Inc. (TVTX) | Director | Sell | 8,000 | $360,000 |
| 2025-12-29 | Indaptus Therapeutics, Inc. (INDP) | Co-Chief Executive Officer | Buy | 216,617 | $439,733 |
| 2025-07-29 | Indaptus Therapeutics, Inc. (INDP) | Chief Executive Officer | Buy | 6,068 | $50,364 |
| 2025-05-16 | Travere Therapeutics, Inc. (TVTX) | Director | Buy | 6,500 | $0 |
Source: SEC Form 4 filings · as of 2026-09-11